NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
1.410
+0.060 (4.44%)
Apr 25, 2025, 4:00 PM EDT - Market closed
NanoViricides Employees
NanoViricides had 7 employees as of June 30, 2024. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,337,824
Market Cap
22.21M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NNVC News
- 13 days ago - Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak - Accesswire
- 6 weeks ago - NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company - Accesswire
- 7 weeks ago - Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan - Accesswire
- 2 months ago - NanoViricides, Inc. Has Filed its Quarterly Report - Accesswire
- 2 months ago - NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape - Accesswire
- 3 months ago - NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025 - Accesswire
- 3 months ago - NanoViricides Engages CRO for Phase II Clinical Trial - Accesswire
- 3 months ago - NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025 - Accesswire